A/S Novo Nordisk (preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Responsible for batch release of the finished medicinal product; preparation, filling, and quality control of bulk products (1.5 mL and 3 mL cartridges). Assembly, labeling, and packaging of the finished medicinal product (semaglutide, solution for injection, 1.5 mL and 3 mL, pre-filled pen PDS290 for semaglutide))
UkraineAll drugs from this manufacturer
-
The drug is intended for body weight management in adults with obesity or overweight (in the presence of comorbidities), as well as in children aged 12 years and older with obesity.
Dosage form: solution for injection
Active substance Dosage semaglutide 0.68 mg/ml ATC: A10BJ06
-
The drug is intended for body weight management in adults (for obesity or overweight with comorbidities) and children aged 12 years and older (for obesity and weight over 60 kg) as an adjunct to a reduced-calorie diet and increased physical activity.
Dosage form: solution for injection
Active substance Dosage semaglutide 1.34 mg/ml ATC: A10BJ06
-
The drug is intended for body weight management as an adjunct to a reduced-calorie diet and increased physical activity. It is used by adults with obesity or overweight (in the presence of comorbidities), as well as children aged 12 years and older with obesity.
Dosage form: solution for injection
Active substance Dosage semaglutide 1.34 mg/ml ATC: A10BJ06
-
The drug is intended for body weight management in adults with obesity or overweight (in the presence of comorbidities), as well as in children aged 12 years and older with obesity.
Dosage form: solution for injection
Active substance Dosage semaglutide 2.27 mg/ml ATC: A10BJ06
-
The drug is intended for body weight management in adults and children aged 12 years and older with obesity or overweight (in the presence of weight-related comorbidities).
Dosage form: solution for injection
Active substance Dosage semaglutide 3.2 mg/ml ATC: A10BJ06